Suppr超能文献

维持性血液透析开始后早期死亡率:系统评价和荟萃分析。

Early Mortality Rates After Commencement of Maintenance Hemodialysis: A Systematic Review and Meta-Analysis.

机构信息

Department of Renal Medicine, Hull University Teaching Hospitals NHS Trust, Hull, UK.

Hull York Medical School, Hull, UK.

出版信息

Ther Apher Dial. 2020 Jun;24(3):275-284. doi: 10.1111/1744-9987.13437. Epub 2019 Nov 3.

Abstract

Mortality rates are reported to be high soon after the commencement of maintenance HD for ESRD. Our aim was to estimate early mortality rates (deaths within 180 days of starting therapy), through a systematic review of literature, in this patient population. Medline and EMBASE were searched for publications between 1 January 1985 and 31 December 2017. Observational studies reporting deaths involving adults commencing HD were included. The Quality in Prognosis Studies tool was used to assess risk of bias in studies. Crude mortality rates (expressed in 100 person-years) and age-standardized mortality ratios (SMR) were calculated. Meta-analyses of these rates were conducted for studies with lowest risk of bias (i.e. highest quality). In total, 32 studies were included (combined population: 1 083 264) representing 283 277 person-years of observation; median follow-up: 90 days. Mortality rates ranged between 12.8 and 55.6 per 100 person-years. Cardiovascular causes accounted for the majority of early deaths. Meta-analysis of high-quality studies showed an overall crude mortality rate of 32.6 per 100 person-years (95% CI 32.4-32.8). This equates to 16.3% mortality in first 180 days of starting HD. Six high-quality studies contained sufficient data for calculation of SMR. Meta-analysis of SMRs showed that patients starting HD therapy sustain 8.8 times higher mortality rates compared to the general population. We have combined the results of high-quality studies to produce new estimates of early mortality rates after commencement of HD therapy. This information can help relay more reliable prognostic information to this patient population.

摘要

死亡率据报道在开始维持性血液透析(ESRD)后很快就会升高。我们的目的是通过对该患者人群的文献系统评价来评估早期死亡率(开始治疗后 180 天内死亡)。检索了 Medline 和 EMBASE 自 1985 年 1 月 1 日至 2017 年 12 月 31 日的出版物。纳入了报告涉及开始接受 HD 的成年人死亡的观察性研究。使用预后研究质量工具评估研究中的偏倚风险。计算了粗死亡率(以每 100 人年表示)和年龄标准化死亡率比(SMR)。对最低偏倚风险(即最高质量)的研究进行了这些比率的荟萃分析。共纳入 32 项研究(合并人群:1083264 人),共观察了 283277 人年;中位随访时间为 90 天。死亡率范围为每 100 人年 12.8 至 55.6。心血管原因导致了大多数早期死亡。高质量研究的荟萃分析显示,总体粗死亡率为 32.6/100 人年(95%CI 32.4-32.8)。这相当于开始 HD 治疗后 180 天内的死亡率为 16.3%。有 6 项高质量研究有足够的数据计算 SMR。SMR 的荟萃分析表明,开始 HD 治疗的患者死亡率比一般人群高 8.8 倍。我们合并了高质量研究的结果,得出了开始 HD 治疗后早期死亡率的新估计值。这些信息可以帮助向该患者人群提供更可靠的预后信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验